CombiMatrix stock is intended to reflect the performance of Acacia Research's subsidiary, CombiMatrix Corporation. The Acacia Research -- CombiMatrix stock is a class of common stock of Acacia Research and is not a separately issued stock.
The CombiMatrix group, consisting of its wholly-owned subsidiary CombiMatrix Corporation, is developing a platform technology that has a wide range of applications, from DNA synthesis/diagnostics to immunochemical detection. The platform allows the company to rapidly produce customizable active biochips, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. The company is designing its products principally to be responsive to the needs of pharmaceutical, biotechnology, and academic researchers in analyzing raw genomic data in the discovery and development of pharmaceutical products. Information about Acacia Research Corporation is available at www.acaciaresearch.com. Information about CombiMatrix Corporation is available at www.combimatrix.com |
